[1]
Kevin Tandarto, Eko Adhi Pangarsa, Daniel Rizky, Budi Setiawan, Damai Santosa, Ika Kartiyani, Vina Yunarvika, Desta Nur Ewika Ardini, Damianus Galih Panunggal and Catharina Suharti 2025. Comparative efficacy and safety of tislelizumab and pembrolizumab in advanced squamous non-small cell lung cancer: a systematic review and meta-analysis. Indonesian Journal of Biomedicine and Clinical Sciences. 57, 3 (Sep. 2025), 98. DOI:https://doi.org/10.22146/inajbcs.v57i3.Supplement.24310.